ACHILLES THERAPEUTICS PLC shareholders Q3 2023

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

ACHILLES THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$10,087,97915.03%
Artal Group S.A. 2,255,375$2,0520.09%
Redmile Group, LLC 1,608,089$1,463,2000.07%
Forefront Analytics, LLC 78,169$71,1260.04%
Baker Brothers Advisors 2,557,149$2,326,7500.01%
Point72 Asset Management, L.P. 1,413,809$1,286,4250.00%
XTX Topco Ltd 21,084$19,1840.00%
Coppell Advisory Solutions LLC 1,000$5,5600.00%
Renaissance Technologies 437,528$3980.00%
JPMORGAN CHASE & CO 989$9000.00%
ROYAL BANK OF CANADA 35$00.00%
RAYMOND JAMES & ASSOCIATES 13,105$11,9240.00%
BANK OF AMERICA CORP /DE/ 73,242$66,5770.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 21,590$19,6440.00%
MILLENNIUM MANAGEMENT LLC 16,278$14,8110.00%
MORGAN STANLEY 50,020$45,5130.00%
Citadel Advisors 57,626$52,4340.00%
Qube Research & Technologies Ltd 73$660.00%
External links

This page lists ACHILLES THERAPEUTICS PLC's shareholders in Q3 2023. To view ACHILLES THERAPEUTICS PLC's shareholder history, click here.